ABIVAX Société Anonyme
ABVX
$82.28
-$3.59-4.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -48.98% | 6.68% |
| Total Other Revenue | -33.41% | 127.20% | 135.50% | 120.96% | 107.41% |
| Total Revenue | -33.41% | 127.20% | 135.50% | 120.96% | 107.41% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -33.41% | 127.20% | 135.50% | 120.96% | 107.41% |
| SG&A Expenses | -21.04% | 5.18% | 34.90% | 103.50% | 271.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2,330.78% | -2,907.15% | -3,426.52% | -2,236.95% | -153.18% |
| Total Operating Expenses | 8.14% | 16.60% | 39.29% | 74.80% | 137.28% |
| Operating Income | -10.36% | -13.26% | -35.84% | -72.71% | -139.12% |
| Income Before Tax | -10.69% | -11.63% | -19.31% | -49.32% | -99.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.69% | -11.63% | -19.31% | -49.32% | -99.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.69% | -11.63% | -19.31% | -49.32% | -99.39% |
| EBIT | -10.36% | -13.26% | -35.84% | -72.71% | -139.12% |
| EBITDA | -10.27% | -13.07% | -35.73% | -73.16% | -139.71% |
| EPS Basic | 3.18% | 12.18% | 16.64% | 8.24% | -0.88% |
| Normalized Basic EPS | 6.28% | 14.94% | 17.46% | 5.84% | -7.33% |
| EPS Diluted | 3.18% | 12.18% | 16.64% | 8.24% | -0.88% |
| Normalized Diluted EPS | 6.28% | 14.94% | 17.46% | 5.84% | -7.33% |
| Average Basic Shares Outstanding | 11.88% | 26.78% | 46.39% | 66.76% | 97.36% |
| Average Diluted Shares Outstanding | 11.88% | 26.78% | 46.39% | 66.76% | 97.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |